IBOV 192,114.55 ▲ 2.63% IPSA 10,916.59 ▲ 0.08% IPC MEX 63,828.60 ▼ 0.60% MERVAL 2,767,663 ▲ 0.32% COLCAP 2,515.02 ▼ 0.59% BVL PERÚ 59,751.67 ▲ 0.18% USD/BRL5.22▼ 0.03% USD/MXN18.15▼ 0.83% USD/CLP989.60▲ 0.35% USD/COP3,254▼ 1.77% USD/PEN3.43▼ 0.53% USD/ARS1,524▼ 0.04% USD/UYU40.46▲ 3.55% USD/PYG5,821▲ 2.69% USD/BOB11.93▲ 2.09% USD/DOP59.90▲ 0.67% USD/CRC456.38▲ 3.02% USD/GTQ7.64▲ 3.14% USD/HNL26.86▲ 3.19% USD/NIO36.62▲ 2.63% USD/VES864.39▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.69▲ 1.67% EUR/BRL5.87▲ 0.03% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 192,114.55 ▲ 2.63% IPSA 10,916.59 ▲ 0.08% IPC MEX 63,828.60 ▼ 0.60% MERVAL 2,767,663 ▲ 0.32% COLCAP 2,515.02 ▼ 0.59% BVL PERÚ 59,751.67 ▲ 0.18% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Friday, October 2, 2026

Earnings Market Reports

Q2 2025: What’s Really Happening at Assaí, Lojas Renner, and Fleury

Three big Brazilian companies—Assaí, Lojas Renner, and Fleury—just published their second quarter financial updates

By RT Staff Reporters · August 8, 2025 · 3 min read
Q2 2025: What’s Really Happening at Assaí, Lojas Renner, and Fleury
Q2 2025: What’s Really Happening at Assaí, Lojas Renner, and Fleury.

Three big Brazilian companies—Assaí, Lojas Renner, and Fleury—just published their second quarter financial updates.

Their results, straight from official company filings, reveal not just solid numbers but real insight into how these firms are handling the tough business climate in Brazil. Each of these companies is making sharp decisions to balance growth, debt, and change.

Assaí: Shifting Gears after a Massive Expansion

Assaí, one of Brazil’s largest wholesale grocery chains, posted a net profit of R$264 million ($46 million) for the quarter—a 60% rise compared to last year.

This did not happen because of luck. Assaí put real effort into opening new stores and running them more efficiently. Total revenue for the quarter was R$19 billion ($3,333 million). Same-store sales climbed 4.6%.

Their EBITDA, which shows profit before things like taxes and interest, improved by almost 12% to R$1.08 billion ($189 million). Here’s the catch: those results come with real costs.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Brazil votes Sunday: Lula 45%, Flávio 40%, and the 50% line”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

Assaí had financial losses of R$565 million ($99 million) due to Brazil’s high interest rates. The company’s debt is still high, even though it has come down a little. Net debt to EBITDA is now 3.17, down from 3.65 last year.

Q2 2025: What’s Really Happening at Assaí, Lojas Renner, and Fleury
Q2 2025: What’s Really Happening at Assaí, Lojas Renner, and Fleury.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Assaí now plans to slow down its breakneck expansion. Instead of opening 20 stores next year, they’re aiming for 10, and for this year plan investments between R$1 billion ($175 million) and R$1.2 billion ($210 million).

Assaí’s big story: it’s learned from its rapid growth spree and is now focused on managing debt and running stores better, not just adding more. It wants to make its current stores more profitable before risking more expansion.

Lojas Renner: Keeping Shoppers—and Their Wallets

Lojas Renner, a major clothing retailer, had a net profit of R$404.5 million ($71 million), up 28.4% from a year ago. The company’s revenue hit R$3.6 billion ($632 million). Same-store sales jumped 18.6%, much faster than most retailers in the country.

Lojas Renner also saw its gross profit hit R$2.1 billion ($368 million). Its operating expenses, now at R$1.3 billion ($228 million), went up because of both higher sales and cost pressures.

The company is also growing its financial arm. Its Realize division had positive results, mainly because shoppers kept borrowing and repaying on time.

Total adjusted EBITDA came in strong at R$891 million ($156 million). Net debt stands at R$1.2 billion ($210 million), better than the R$1.8 billion ($316 million) it faced last year.

But there are warning signs. Financial costs hit the bottom line, especially as the company had fewer tax breaks to offset debt costs.

Renner’s leadership focuses hard on digital sales, supply chain improvements, and keeping debts under control. The real story is that Renner is winning more market share, but costs and credit risks still loom.

Fleury: Caught between Costs and New Investments

Fleury, a leader in diagnostic healthcare, earned R$152.3 million ($27 million) this quarter, but profit dropped 12% compared to last year. Official filings say Fleury dealt with both external shocks and internal change.

There were more holidays, fewer business days, and costs from investing in new technology. These changes made a big difference to results.

Nonetheless, total revenue inched up to R$2.02 billion ($354 million), helped by 7.2% growth in walk-in and mobile testing. But Fleury’s other business lines—like labs and hospitals—continued to shrink.

Technology spending grew 45%, aiming to make the business more efficient in the long run. For the full year, investments should reach 6% to 6.5% of revenue.

Fleury’s net debt to EBITDA ratio sits at 1.1, which is bearable but rising. Fleury approved a R$169 million ($30 million) payout to shareholders, sticking to a steady policy despite headwinds.

What’s beneath the surface: Fleury faces fierce competition, needs to modernize, but must live with unpredictable demand and costly upgrades. Investments may pay off long-term but are weighing down current profits.

Live Company IntelligenceFleury S.A. — the full investor dossierInside: live share price, market cap, three-year financials, valuation, ESG and peer benchmarks — plus the latest Rio Times coverage.
F
◆ Live Company Intelligence
Fleury
SA: FLRY3FLRY3HealthcareDiagnostics & Research28,000 employees
R$12.91B
Market cap

Valuation & profitability

Market capR$12.91B
Revenue (TTM)R$8.79B
P / E ratio20.5
Profit margin8.0%
Return on equity12.6%

Price & risk

52-wk low
$13.01
52-wk high
$23.93
Beta (volatility)0.21
200-day average$16.82

Revenue trend · 6y

20202025
Latest R$8.29B

Ownership

Institutions27.5%
Shares outstanding544M

Dividend

Yield5.3%
Payout ratio90.7%
Fwd. annual$1.61
What Fleury does. Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine,…
Data: RT fundamentals (FLRY3.SA) · figures in BRL · as of 2 Oct 2026More company intelligence →

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Read More from The Rio Times

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Brazil votes Sunday: Lula 45%, Flávio 40%, and the 50% line”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.